カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のケトロラク トロメタミン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Ketorolac Tromethamine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19438）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19438
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：112
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のケトロラク トロメタミン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ケトロラク トロメタミン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のケトロラク トロメタミンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ケトロラク トロメタミン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・注射剤、点眼剤、点鼻剤、内服剤

用途別セグメントは次のように区分されます。
・痛み短期治療、眼科手術

世界のケトロラク トロメタミン市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Omeros Corporation、Egalet US Inc.、Allergan、Dr. Reddy’s Laboratories、Teva、Mylan、West Ward Pharmaceuticals、Fresenius Kabi、Apotex、Sandoz、Amphastar Pharmaceuticals、Gland Pharma Limited、Akorn、Sun Pharmaceutical、Sagent Pharmaceuticals、Aurobindo Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ケトロラク トロメタミン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なケトロラク トロメタミンメーカーの企業概要、2019年～2022年までのケトロラク トロメタミンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なケトロラク トロメタミンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ケトロラク トロメタミンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのケトロラク トロメタミンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのケトロラク トロメタミン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびケトロラク トロメタミンの産業チェーンを掲載しています。
・第13、14、15章では、ケトロラク トロメタミンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ケトロラク トロメタミンの概要
- 種類別分析（2017年vs2021年vs2028年）：注射剤、点眼剤、点鼻剤、内服剤
- 用途別分析（2017年vs2021年vs2028年）：痛み短期治療、眼科手術
- 世界のケトロラク トロメタミン市場規模・予測
- 世界のケトロラク トロメタミン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Pfizer、Omeros Corporation、Egalet US Inc.、Allergan、Dr. Reddy’s Laboratories、Teva、Mylan、West Ward Pharmaceuticals、Fresenius Kabi、Apotex、Sandoz、Amphastar Pharmaceuticals、Gland Pharma Limited、Akorn、Sun Pharmaceutical、Sagent Pharmaceuticals、Aurobindo Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：注射剤、点眼剤、点鼻剤、内服剤
・用途別分析2017年-2028年：痛み短期治療、眼科手術
・ケトロラク トロメタミンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ケトロラク トロメタミンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ケトロラク トロメタミンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ケトロラク トロメタミンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ケトロラク トロメタミンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Ketorolac Tromethamine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Ketorolac Tromethamine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Short-term treatment of pain accounting for % of the Ketorolac Tromethamine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Ketorolac Tromethamine include Pfizer, Omeros Corporation, Egalet US Inc., Allergan, and Dr. Reddy’s Laboratories, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Ketorolac Tromethamine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Ophthalmic
Nasal
Oral tablet
Market segment by Application can be divided into
Short-term treatment of pain
Ophthalmic Surgery
The key market players for global Ketorolac Tromethamine market are listed below:
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ketorolac Tromethamine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ketorolac Tromethamine, with price, sales, revenue and global market share of Ketorolac Tromethamine from 2019 to 2022.
Chapter 3, the Ketorolac Tromethamine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ketorolac Tromethamine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Ketorolac Tromethamine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Ketorolac Tromethamine.
Chapter 13, 14, and 15, to describe Ketorolac Tromethamine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Ketorolac Tromethamine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ketorolac Tromethamine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injection
1.2.3 Ophthalmic
1.2.4 Nasal
1.2.5 Oral tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Ketorolac Tromethamine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Short-term treatment of pain
1.3.3 Ophthalmic Surgery
1.4 Global Ketorolac Tromethamine Market Size & Forecast
1.4.1 Global Ketorolac Tromethamine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Ketorolac Tromethamine Sales in Volume (2017-2028)
1.4.3 Global Ketorolac Tromethamine Price (2017-2028)
1.5 Global Ketorolac Tromethamine Production Capacity Analysis
1.5.1 Global Ketorolac Tromethamine Total Production Capacity (2017-2028)
1.5.2 Global Ketorolac Tromethamine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Ketorolac Tromethamine Market Drivers
1.6.2 Ketorolac Tromethamine Market Restraints
1.6.3 Ketorolac Tromethamine Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Ketorolac Tromethamine Product and Services
2.1.4 Pfizer Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Omeros Corporation
2.2.1 Omeros Corporation Details
2.2.2 Omeros Corporation Major Business
2.2.3 Omeros Corporation Ketorolac Tromethamine Product and Services
2.2.4 Omeros Corporation Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Egalet US Inc.
2.3.1 Egalet US Inc. Details
2.3.2 Egalet US Inc. Major Business
2.3.3 Egalet US Inc. Ketorolac Tromethamine Product and Services
2.3.4 Egalet US Inc. Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business
2.4.3 Allergan Ketorolac Tromethamine Product and Services
2.4.4 Allergan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dr. Reddy’s Laboratories
2.5.1 Dr. Reddy’s Laboratories Details
2.5.2 Dr. Reddy’s Laboratories Major Business
2.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product and Services
2.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Ketorolac Tromethamine Product and Services
2.6.4 Teva Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Ketorolac Tromethamine Product and Services
2.7.4 Mylan Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 West Ward Pharmaceuticals
2.8.1 West Ward Pharmaceuticals Details
2.8.2 West Ward Pharmaceuticals Major Business
2.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Product and Services
2.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Ketorolac Tromethamine Product and Services
2.9.4 Fresenius Kabi Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business
2.10.3 Apotex Ketorolac Tromethamine Product and Services
2.10.4 Apotex Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Sandoz
2.11.1 Sandoz Details
2.11.2 Sandoz Major Business
2.11.3 Sandoz Ketorolac Tromethamine Product and Services
2.11.4 Sandoz Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Amphastar Pharmaceuticals
2.12.1 Amphastar Pharmaceuticals Details
2.12.2 Amphastar Pharmaceuticals Major Business
2.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Product and Services
2.12.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Gland Pharma Limited
2.13.1 Gland Pharma Limited Details
2.13.2 Gland Pharma Limited Major Business
2.13.3 Gland Pharma Limited Ketorolac Tromethamine Product and Services
2.13.4 Gland Pharma Limited Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Akorn
2.14.1 Akorn Details
2.14.2 Akorn Major Business
2.14.3 Akorn Ketorolac Tromethamine Product and Services
2.14.4 Akorn Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Sun Pharmaceutical
2.15.1 Sun Pharmaceutical Details
2.15.2 Sun Pharmaceutical Major Business
2.15.3 Sun Pharmaceutical Ketorolac Tromethamine Product and Services
2.15.4 Sun Pharmaceutical Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sagent Pharmaceuticals
2.16.1 Sagent Pharmaceuticals Details
2.16.2 Sagent Pharmaceuticals Major Business
2.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Product and Services
2.16.4 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Aurobindo Pharma
2.17.1 Aurobindo Pharma Details
2.17.2 Aurobindo Pharma Major Business
2.17.3 Aurobindo Pharma Ketorolac Tromethamine Product and Services
2.17.4 Aurobindo Pharma Ketorolac Tromethamine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Ketorolac Tromethamine Breakdown Data by Manufacturer
3.1 Global Ketorolac Tromethamine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Ketorolac Tromethamine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Ketorolac Tromethamine
3.4 Market Concentration Rate
3.4.1 Top 3 Ketorolac Tromethamine Manufacturer Market Share in 2021
3.4.2 Top 6 Ketorolac Tromethamine Manufacturer Market Share in 2021
3.5 Global Ketorolac Tromethamine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Ketorolac Tromethamine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Ketorolac Tromethamine Market Size by Region
4.1.1 Global Ketorolac Tromethamine Sales in Volume by Region (2017-2028)
4.1.2 Global Ketorolac Tromethamine Revenue by Region (2017-2028)
4.2 North America Ketorolac Tromethamine Revenue (2017-2028)
4.3 Europe Ketorolac Tromethamine Revenue (2017-2028)
4.4 Asia-Pacific Ketorolac Tromethamine Revenue (2017-2028)
4.5 South America Ketorolac Tromethamine Revenue (2017-2028)
4.6 Middle East and Africa Ketorolac Tromethamine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Ketorolac Tromethamine Sales in Volume by Type (2017-2028)
5.2 Global Ketorolac Tromethamine Revenue by Type (2017-2028)
5.3 Global Ketorolac Tromethamine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Ketorolac Tromethamine Sales in Volume by Application (2017-2028)
6.2 Global Ketorolac Tromethamine Revenue by Application (2017-2028)
6.3 Global Ketorolac Tromethamine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Ketorolac Tromethamine Sales by Type (2017-2028)
7.2 North America Ketorolac Tromethamine Sales by Application (2017-2028)
7.3 North America Ketorolac Tromethamine Market Size by Country
7.3.1 North America Ketorolac Tromethamine Sales in Volume by Country (2017-2028)
7.3.2 North America Ketorolac Tromethamine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Ketorolac Tromethamine Sales by Type (2017-2028)
8.2 Europe Ketorolac Tromethamine Sales by Application (2017-2028)
8.3 Europe Ketorolac Tromethamine Market Size by Country
8.3.1 Europe Ketorolac Tromethamine Sales in Volume by Country (2017-2028)
8.3.2 Europe Ketorolac Tromethamine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Ketorolac Tromethamine Sales by Type (2017-2028)
9.2 Asia-Pacific Ketorolac Tromethamine Sales by Application (2017-2028)
9.3 Asia-Pacific Ketorolac Tromethamine Market Size by Region
9.3.1 Asia-Pacific Ketorolac Tromethamine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Ketorolac Tromethamine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Ketorolac Tromethamine Sales by Type (2017-2028)
10.2 South America Ketorolac Tromethamine Sales by Application (2017-2028)
10.3 South America Ketorolac Tromethamine Market Size by Country
10.3.1 South America Ketorolac Tromethamine Sales in Volume by Country (2017-2028)
10.3.2 South America Ketorolac Tromethamine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2028)
11.2 Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2028)
11.3 Middle East & Africa Ketorolac Tromethamine Market Size by Country
11.3.1 Middle East & Africa Ketorolac Tromethamine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Ketorolac Tromethamine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Ketorolac Tromethamine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Ketorolac Tromethamine
12.3 Ketorolac Tromethamine Production Process
12.4 Ketorolac Tromethamine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Ketorolac Tromethamine Typical Distributors
13.3 Ketorolac Tromethamine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Ketorolac Tromethamine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Ketorolac Tromethamine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Ketorolac Tromethamine Product and Services
Table 6. Pfizer Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Omeros Corporation Major Business
Table 9. Omeros Corporation Ketorolac Tromethamine Product and Services
Table 10. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Egalet US Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Egalet US Inc. Major Business
Table 13. Egalet US Inc. Ketorolac Tromethamine Product and Services
Table 14. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Allergan Basic Information, Manufacturing Base and Competitors
Table 16. Allergan Major Business
Table 17. Allergan Ketorolac Tromethamine Product and Services
Table 18. Allergan Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr. Reddy’s Laboratories Major Business
Table 21. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product and Services
Table 22. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Teva Basic Information, Manufacturing Base and Competitors
Table 24. Teva Major Business
Table 25. Teva Ketorolac Tromethamine Product and Services
Table 26. Teva Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Mylan Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Major Business
Table 29. Mylan Ketorolac Tromethamine Product and Services
Table 30. Mylan Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. West Ward Pharmaceuticals Major Business
Table 33. West Ward Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 34. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 36. Fresenius Kabi Major Business
Table 37. Fresenius Kabi Ketorolac Tromethamine Product and Services
Table 38. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Apotex Basic Information, Manufacturing Base and Competitors
Table 40. Apotex Major Business
Table 41. Apotex Ketorolac Tromethamine Product and Services
Table 42. Apotex Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Sandoz Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz Major Business
Table 45. Sandoz Ketorolac Tromethamine Product and Services
Table 46. Sandoz Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Amphastar Pharmaceuticals Major Business
Table 49. Amphastar Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 50. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Gland Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 52. Gland Pharma Limited Major Business
Table 53. Gland Pharma Limited Ketorolac Tromethamine Product and Services
Table 54. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Akorn Basic Information, Manufacturing Base and Competitors
Table 56. Akorn Major Business
Table 57. Akorn Ketorolac Tromethamine Product and Services
Table 58. Akorn Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Sun Pharmaceutical Major Business
Table 61. Sun Pharmaceutical Ketorolac Tromethamine Product and Services
Table 62. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Sagent Pharmaceuticals Major Business
Table 65. Sagent Pharmaceuticals Ketorolac Tromethamine Product and Services
Table 66. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Aurobindo Pharma Major Business
Table 69. Aurobindo Pharma Ketorolac Tromethamine Product and Services
Table 70. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Ketorolac Tromethamine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 72. Global Ketorolac Tromethamine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Ketorolac Tromethamine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Ketorolac Tromethamine Production Capacity by Company, (K Units): 2020 VS 2021
Table 75. Head Office and Ketorolac Tromethamine Production Site of Key Manufacturer
Table 76. Ketorolac Tromethamine New Entrant and Capacity Expansion Plans
Table 77. Ketorolac Tromethamine Mergers & Acquisitions in the Past Five Years
Table 78. Global Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)
Table 79. Global Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)
Table 80. Global Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 83. Global Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 84. Global Ketorolac Tromethamine Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Ketorolac Tromethamine Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Ketorolac Tromethamine Price by Type (2017-2022) & (USD/Unit)
Table 87. Global Ketorolac Tromethamine Price by Type (2023-2028) & (USD/Unit)
Table 88. Global Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 89. Global Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 90. Global Ketorolac Tromethamine Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Ketorolac Tromethamine Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Ketorolac Tromethamine Price by Application (2017-2022) & (USD/Unit)
Table 93. Global Ketorolac Tromethamine Price by Application (2023-2028) & (USD/Unit)
Table 94. North America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 95. North America Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)
Table 96. North America Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 99. North America Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 100. North America Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 101. North America Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 102. Europe Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 103. Europe Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)
Table 104. Europe Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 107. Europe Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 108. Europe Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 109. Europe Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 110. Asia-Pacific Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)
Table 111. Asia-Pacific Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)
Table 112. Asia-Pacific Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 115. Asia-Pacific Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 116. Asia-Pacific Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 117. Asia-Pacific Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 118. South America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units)
Table 119. South America Ketorolac Tromethamine Sales by Country (2023-2028) & (K Units)
Table 120. South America Ketorolac Tromethamine Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Ketorolac Tromethamine Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 123. South America Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 124. South America Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 125. South America Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 126. Middle East & Africa Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units)
Table 127. Middle East & Africa Ketorolac Tromethamine Sales by Region (2023-2028) & (K Units)
Table 128. Middle East & Africa Ketorolac Tromethamine Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Ketorolac Tromethamine Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units)
Table 131. Middle East & Africa Ketorolac Tromethamine Sales by Type (2023-2028) & (K Units)
Table 132. Middle East & Africa Ketorolac Tromethamine Sales by Application (2017-2022) & (K Units)
Table 133. Middle East & Africa Ketorolac Tromethamine Sales by Application (2023-2028) & (K Units)
Table 134. Ketorolac Tromethamine Raw Material
Table 135. Key Manufacturers of Ketorolac Tromethamine Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Ketorolac Tromethamine Typical Distributors
Table 139. Ketorolac Tromethamine Typical Customers
List of Figures
Figure 1. Ketorolac Tromethamine Picture
Figure 2. Global Ketorolac Tromethamine Revenue Market Share by Type in 2021
Figure 3. Injection
Figure 4. Ophthalmic
Figure 5. Nasal
Figure 6. Oral tablet
Figure 7. Global Ketorolac Tromethamine Revenue Market Share by Application in 2021
Figure 8. Short-term treatment of pain
Figure 9. Ophthalmic Surgery
Figure 10. Global Ketorolac Tromethamine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Ketorolac Tromethamine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Ketorolac Tromethamine Sales (2017-2028) & (K Units)
Figure 13. Global Ketorolac Tromethamine Price (2017-2028) & (USD/Unit)
Figure 14. Global Ketorolac Tromethamine Production Capacity (2017-2028) & (K Units)
Figure 15. Global Ketorolac Tromethamine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Ketorolac Tromethamine Market Drivers
Figure 17. Ketorolac Tromethamine Market Restraints
Figure 18. Ketorolac Tromethamine Market Trends
Figure 19. Global Ketorolac Tromethamine Sales Market Share by Manufacturer in 2021
Figure 20. Global Ketorolac Tromethamine Revenue Market Share by Manufacturer in 2021
Figure 21. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Ketorolac Tromethamine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2028)
Figure 25. Global Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)
Figure 26. North America Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)
Figure 29. South America Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Ketorolac Tromethamine Revenue (2017-2028) & (USD Million)
Figure 31. Global Ketorolac Tromethamine Sales Market Share by Type (2017-2028)
Figure 32. Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2028)
Figure 33. Global Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 35. Global Ketorolac Tromethamine Revenue Market Share by Application (2017-2028)
Figure 36. Global Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Ketorolac Tromethamine Sales Market Share by Type (2017-2028)
Figure 38. North America Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 39. North America Ketorolac Tromethamine Sales Market Share by Country (2017-2028)
Figure 40. North America Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)
Figure 41. United States Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Ketorolac Tromethamine Sales Market Share by Type (2017-2028)
Figure 45. Europe Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 46. Europe Ketorolac Tromethamine Sales Market Share by Country (2017-2028)
Figure 47. Europe Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)
Figure 57. China Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Ketorolac Tromethamine Sales Market Share by Type (2017-2028)
Figure 64. South America Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 65. South America Ketorolac Tromethamine Sales Market Share by Country (2017-2028)
Figure 66. South America Ketorolac Tromethamine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Ketorolac Tromethamine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Ketorolac Tromethamine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Ketorolac Tromethamine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Ketorolac Tromethamine in 2021
Figure 78. Manufacturing Process Analysis of Ketorolac Tromethamine
Figure 79. Ketorolac Tromethamine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の三次元電気生理ナビゲーションシステム市場2022年：市場規模予測（～2028年）
  • 世界のアンフェタミン薬市場2022年：市場規模予測（～2028年）
  • 世界の金属製冠動脈ステント市場2022年：市場規模予測（～2028年）
  • 世界の経口用レボチロキシンナトリウム市場2022年：市場規模予測（～2028年）
  • 世界の使い捨て型歯科滅菌針市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19438 )"世界のケトロラク トロメタミン市場2022年：市場規模予測（～2028年）" (英文：Global Ketorolac Tromethamine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。